{
  "id": "ba2e822ed4833c6a",
  "title": "NRx Pharmaceuticals , Inc .: NRx Pharmaceuticals ( Nasdaq : NRXP ) Announces 70 , 000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX - 100 Approval",
  "description": "20260114T123000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-01/67432334-nrx-pharmaceuticals-inc-nrx-pharmaceuticals-nasdaq-nrxp-announces-70-000-patient-data-on-real-world-use-of-ketamine-for-treatment-of-suicidal-dep-399.htm",
  "published_at": "20260114T123000Z",
  "fetched_at": "2026-01-15T00:21:56.842948+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-01/67432334-nrx-pharmaceuticals-inc-nrx-pharmaceuticals-nasdaq-nrxp-announces-70-000-patient-data-on-real-world-use-of-ketamine-for-treatment-of-suicidal-dep-399.htm",
    "url_mobile": "",
    "title": "NRx Pharmaceuticals , Inc .: NRx Pharmaceuticals ( Nasdaq : NRXP ) Announces 70 , 000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX - 100 Approval",
    "seendate": "20260114T123000Z",
    "socialimage": "https://www.finanznachrichten.de/chart-nrx-pharmaceuticals-inc-aktie-intraklein-tradegate.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}